cell
play
major
role
protect
immun
wide
varieti
pathogen
includ
virus
bacteria
protozoan
parasit
howev
protect
role
cell
leishmania
infect
controversi
mainli
discrep
among
infect
differ
leishmania
speci
differ
leishmania
speci
differ
tropism
divers
reflect
variou
clinic
manifest
induc
henc
surpris
contribut
cell
immun
respons
parasit
depend
clinic
form
speci
caus
discuss
literatur
contribut
cell
immun
respons
leishmania
take
account
variou
clinic
form
experiment
model
cell
recogn
peptid
present
context
major
histocompat
complex
mhc
class
molecul
via
cell
receptor
tcr
although
peptid
present
via
mhci
mainli
deriv
endogen
antigen
variou
exogen
cellassoci
antigen
also
shown
upload
onto
mhci
pathway
process
refer
crosspresent
leishmania
antigen
also
shown
crosspres
bertholet
et
al
vivo
infect
crosspresent
leishmania
antigen
may
result
sever
intern
pathway
direct
infect
receptormedi
uptak
woelb
et
al
intern
apoptot
vesicl
winau
et
al
thu
far
two
differ
process
pathway
propos
earli
work
demonstr
surfac
antigen
l
amazonensi
process
proteasomedepend
manner
within
cytosol
kima
et
al
contrast
recent
studi
show
crosspresent
secret
leishmani
antigen
confin
intraphagosom
process
pathway
tap
proteasomeindepend
bertholet
et
al
activ
antigenspecif
cell
differenti
effector
cell
acquir
capac
kill
target
cell
produc
sever
cytokin
chemokin
kaech
et
al
harti
badovinac
among
variou
cell
subset
shown
play
major
role
fight
sever
protozoan
parasit
jordan
hunter
hallmark
subset
product
tnf
cytotox
capac
woodland
dutton
precis
mechan
underli
cytotox
lymphocyt
ctl
kill
microb
still
poorli
understood
ctl
exert
cytotox
variou
mechan
via
exocytosi
lytic
granula
contain
perforin
granzym
ab
andor
granulysin
interact
fasl
fa
express
target
cell
via
tnf
via
trail
trapani
smyth
studi
also
shown
reactiv
memori
cell
effici
kill
listeria
monocytogen
via
mechan
mediat
involv
induct
radic
oxygen
intermedi
narnimancinelli
et
al
direct
kill
extracellular
pathogen
ctl
also
describ
exampl
ctl
mediat
kill
mycobacterium
tuberculosi
releas
antibacteri
product
stenger
et
al
canaday
et
al
howev
direct
kill
schistosoma
mansoni
ellner
et
al
entamoeba
histolytica
salata
et
al
thought
contactdepend
ctl
also
report
directli
kill
extracellular
toxoplasma
gondii
khan
et
al
interestingli
kill
case
appear
antigenspecif
date
evid
cell
mediat
protect
leishmania
parasit
cytotox
activ
howev
sinc
ctl
observ
variou
mous
model
also
human
patient
possibl
protect
role
leishmaniaspecif
cytotox
cell
exclud
addit
kill
releas
cytokin
chemokin
recent
studi
ascrib
novel
regulatori
role
cell
sun
et
al
palmer
et
al
trandem
et
al
regulatori
cell
repres
transient
state
effector
cell
trandem
et
al
possibl
induc
potent
tcr
stimul
promot
product
immunosuppress
cytokin
zhang
bevan
cell
produc
also
excel
killer
produc
normal
higher
amount
tnf
sun
et
al
palmer
et
al
trandem
et
al
main
function
cell
thought
lie
prevent
immunopatholog
infect
without
affect
kinet
pathogen
clearanc
cell
also
observ
human
patient
infect
l
guyanensi
bourreau
et
al
patient
suffer
postkalaazar
dermal
leishmaniasi
pkdl
ganguli
et
al
role
regulatori
cell
immun
respons
parasit
infect
still
unknown
role
cell
immun
l
major
alway
controversi
earli
studi
balbc
mice
report
cell
main
mediat
protect
follow
cell
deplet
mice
infect
l
major
titu
et
al
hill
et
al
muller
et
al
interestingli
deplet
cell
render
suscept
balbc
mice
resist
l
major
infect
result
obtain
use
cell
deplet
model
suggest
cell
could
potenti
control
l
major
infect
mice
year
later
experi
mice
contradict
find
reveal
cell
essenti
mediat
protect
l
majorinfect
balbc
mice
wang
et
al
moreov
studi
celldefici
mice
demonstr
mice
abl
control
l
major
infect
least
year
suggest
cell
requir
longlast
immun
huber
et
al
contribut
cell
control
primari
l
major
infect
becam
less
import
also
strong
evid
cell
primari
cell
involv
mediat
protect
cutan
leishmaniasi
reiner
locksley
loui
et
al
sack
nobentrauth
sever
studi
demonstr
cell
produc
essenti
control
l
major
infect
failur
develop
respons
result
suscept
diseas
henc
consensu
reach
mous
gener
respons
lead
suscept
contrast
respons
success
control
infect
without
help
cell
paradigm
later
challeng
new
find
aros
natur
model
infect
metacycl
promastigot
inocul
intraderm
ear
mice
model
celldeplet
mice
fail
control
l
major
infect
cell
thought
necessari
support
respons
belkaid
et
al
discrep
find
low
highparasit
dose
model
clarifi
anoth
work
compar
requir
cell
system
uzonna
et
al
interestingli
low
infect
model
cell
produc
essenti
modul
cell
respons
toward
respons
contrast
mice
inocul
high
l
major
dose
requir
cell
help
gener
protect
respons
cell
requir
optim
product
cell
also
propos
highdos
l
major
infect
model
balbc
mice
herath
et
al
moreov
cellderiv
report
contribut
induct
nitric
oxid
product
macrophag
experiment
cutan
leishmaniasi
stefani
et
al
although
role
cellsderiv
clarifi
littl
known
involv
cytotox
cell
cutan
leishmaniasi
lowdos
model
l
major
infect
cell
respons
shown
protect
also
mediat
patholog
belkaid
et
al
henc
possibl
ctl
may
involv
ulcer
skin
lesion
tissu
disrupt
suggest
perhap
two
type
cell
effector
gener
l
major
infect
antigenspecif
cell
produc
lack
cytotox
activ
ctl
potent
killer
produc
littl
promot
patholog
although
role
cell
primari
immun
respons
controversi
cell
appear
play
promin
role
protect
mice
secondari
challeng
muller
et
al
inde
antigenspecif
cell
expand
spleen
lymph
node
reinfect
balbc
mice
muller
et
al
expans
correl
substanti
product
thought
essenti
control
leishmania
infect
observ
major
implic
vaccin
design
summari
experiment
cutan
leishmaniasi
cell
necessari
support
protect
respons
product
also
involv
develop
immunopatholog
investig
need
better
identifi
variou
subtyp
cell
aris
cutan
leishmaniasi
contrast
cutan
model
cell
alway
thought
play
major
role
experiment
viscer
leishmaniasi
vl
year
ago
stern
et
al
demonstr
first
time
cell
significantli
contribut
format
granuloma
liver
l
donovaniinfect
mice
inde
cell
deplet
result
impair
granuloma
format
exacerb
liver
diseas
agreement
result
kay
et
al
also
report
delay
onset
decreas
liver
granulomat
respons
nonobes
diabet
mice
express
transgen
molecul
suggest
antigenspecif
cell
requir
proper
granuloma
format
cell
appear
particip
control
parasit
growth
spleen
well
sinc
cell
deplet
chronic
vl
significantli
increas
splenic
parasit
burden
unpublish
observ
underscor
fact
adopt
transfer
antigenspecif
cell
chronic
l
donovani
infect
result
reduct
splenic
parasit
burden
polley
et
al
moreov
therapeut
vaccin
aim
reactiv
cell
chronic
vl
ensu
control
parasit
growth
spleen
joshi
et
al
interestingli
cell
particip
primari
respons
l
donovani
also
major
mediat
resist
upon
reinfect
stern
et
al
inde
protect
abrog
follow
cell
cell
deplet
promin
function
cell
also
describ
l
infantuminfect
mice
use
intraderm
infect
model
ahm
et
al
demonstr
cell
contribut
parasit
clearanc
skin
l
infantuminfect
mice
anoth
studi
also
show
cell
purifi
l
infantuminfect
mice
express
tnf
display
consider
cytotox
activ
cell
express
leishmania
antigen
tsagozi
et
al
interestingli
kill
infect
target
cell
mediat
perforin
fasfasl
pathway
tsagozi
et
al
fasfasl
pathway
also
implic
defens
l
donovani
alexand
et
al
inde
gld
lpr
mice
lack
function
fasfasl
pathway
shown
suscept
l
donovani
addit
classic
cytotox
pathway
novel
counterregulatori
function
subset
cytotox
cell
recent
propos
l
donovani
infect
model
martin
et
al
studi
cell
shown
suppress
regulatori
cell
via
interact
earli
stage
infect
balbc
mice
signal
ra
protein
kinas
c
lead
induct
granzym
perforin
ultim
kill
treg
cell
may
mere
particip
primari
immun
respons
secret
possibl
kill
infect
target
cell
andor
treg
could
also
involv
recruit
inflammatori
cell
mainten
granuloma
inde
studi
use
l
infantum
demonstr
cell
express
rant
tsagozi
et
al
two
chemokin
involv
recruit
cell
inflammatori
site
format
mainten
granuloma
mackay
author
propos
cell
may
thu
involv
granuloma
format
hypothesi
agreement
deplet
data
stern
et
al
show
deplet
cell
result
impair
granuloma
format
ultim
diseas
exacerb
despit
document
evid
cell
strongli
particip
immun
respons
l
donovani
l
infantum
recent
find
suggest
l
donovani
induc
defect
antigenspecif
cell
respons
joshi
et
al
interestingli
mice
infect
l
donovani
gener
cell
respons
limit
clonal
expans
extens
clonal
expans
thought
correl
effect
elimin
pathogen
calcul
cell
may
go
cell
divis
first
week
pathogen
inocul
badovinac
et
al
massiv
clonal
expans
observ
viral
infect
also
follow
inject
irradi
plasmodium
berghei
sporozoit
sano
et
al
l
donovani
infect
cell
underw
least
round
divis
fail
accumul
spleen
joshi
et
al
moreov
cell
clonal
expans
express
marker
typic
associ
enddifferenti
effector
cell
fa
bankoti
unpublish
caus
limit
expans
yet
unknown
may
depend
sever
factor
one
possibl
explan
limit
antigen
avail
may
result
poor
antigenprocess
present
process
leishmania
antigen
thought
confin
tapindepend
intraphagosom
pathway
less
effici
requir
higher
amount
antigen
endoplasm
reticulumbas
tapdepend
crosspresent
pathway
bertholet
et
al
furthermor
major
surfac
proteas
leishmania
shown
cleav
epitop
within
parasitophor
vacuol
reduc
antigen
avail
garcia
et
al
henc
leishmania
antigen
may
poorli
present
poor
present
may
enough
induc
sustain
massiv
clonal
expans
antigenspecif
cell
nonetheless
antigen
may
suddenli
avail
larg
amount
later
l
donovani
infect
sinc
cell
undergo
second
round
activ
becom
dysfunct
ultim
die
exhaust
joshi
et
al
high
antigen
level
describ
caus
cell
exhaust
chronic
viral
infect
mueller
ahm
research
need
clarifi
mechan
involv
cell
exhaust
chronic
vl
conclus
cell
requir
control
parasit
growth
experiment
vl
reactiv
respons
result
dramat
reduct
parasit
burden
therefor
immun
intervent
target
cell
respons
may
great
therapeut
potenti
vl
role
cell
human
leishmaniasi
patient
still
unclear
seem
depend
variou
speci
parasit
diseas
caus
studi
conduct
human
vl
patient
howev
studi
ascrib
protect
role
cell
agreement
result
obtain
experiment
model
inde
control
l
infantum
infect
shown
associ
cell
also
cell
mari
et
al
interestingli
activ
vl
cell
less
respons
stimul
greater
percentag
stain
posit
annexin
v
compar
healthi
control
clarencio
et
al
observ
correl
well
observ
mice
experiment
infect
l
donovani
cell
becam
increasingli
dysfunct
chronic
infect
die
exhaust
joshi
et
al
whether
human
cell
also
display
sign
exhaust
activ
vl
still
remain
test
anoth
studi
investig
cell
respons
patient
infect
l
chagasi
reveal
frequenc
cell
significantli
decreas
spleen
patient
activ
vl
clarencio
et
al
contrast
cell
seem
retain
bone
marrow
vl
patient
integrin
subunit
human
lack
caus
leukocyt
adhes
defici
disord
character
lack
leukocyt
extravas
blood
tissu
bunt
et
al
except
fact
cell
appear
granuloma
dog
asymptomat
vl
sanchez
et
al
littl
known
function
cell
vl
whether
cell
lack
express
similar
migratori
capac
effector
function
counterpart
frequenc
cell
reduc
l
chagasi
patient
also
level
circul
memori
cell
significantli
decreas
activ
vl
hailu
et
al
clarencio
et
al
observ
agreement
find
experiment
model
vl
major
cell
display
effector
phenotyp
chronic
infect
joshi
et
al
although
cell
posit
correl
cure
vl
patient
one
report
suggest
cell
may
contribut
immunopathogenesi
pkdl
ganguli
et
al
inde
patient
suffer
pkdl
show
signific
increas
percentag
cell
produc
disappear
cure
ganguli
et
al
cell
thought
play
regulatori
role
differ
viral
infect
model
cell
subset
shown
display
great
cytotox
produc
granzym
b
tnf
sun
et
al
palmer
et
al
trandem
et
al
cell
seem
repres
transient
revers
state
effector
cell
differenti
primari
function
balanc
pathogen
clearanc
bystand
tissu
damag
zhang
bevan
interestingli
viral
model
subset
disappear
infect
clear
henc
possibl
cell
pkdl
patient
actual
kill
parasit
protect
patient
tissu
damag
rather
suppress
protect
respons
studi
need
order
defin
natur
cell
cell
also
activ
particip
immun
respons
cutan
infect
human
observ
lowdos
model
mice
belkaid
et
al
uzonna
et
al
l
major
also
induc
cell
human
patient
respons
associ
diseas
resolut
nateghi
rostami
et
al
cell
observ
larg
number
lesion
l
major
patient
acut
phase
also
heal
process
dacruz
et
al
gaafar
et
al
exact
role
cell
l
major
infect
human
yet
known
major
correl
protect
appear
high
amount
produc
cell
restimul
nateghi
rostami
et
al
vitro
studi
also
demonstr
leishmaniaspecif
ctl
gener
upon
cocultur
human
cell
antigen
l
amazonensi
promastigot
russo
et
al
l
major
parasit
da
conceicaosilva
et
al
moreov
increas
granzym
b
activ
also
found
patient
activ
infect
associ
good
prognosi
bousoffara
et
al
studi
vitro
cytotox
peripher
blood
lymphocyt
l
majorinfect
macrophag
appear
mediat
granzym
b
suggest
ctl
activ
may
involv
control
parasit
growth
possibl
though
cytotox
activ
contribut
diseas
clearanc
also
develop
skin
ulcer
observ
l
majorinfect
mice
belkaid
et
al
strong
cell
expans
also
observ
l
mexicana
patient
heal
process
salaizasuazo
et
al
interestingli
lesion
patient
local
cutan
leishmaniasi
lcl
harbor
higher
number
cell
compar
patient
diffus
cutan
leishmaniasi
dcl
hernandezruiz
et
al
alreadi
observ
vl
patient
cell
dcl
patient
unlik
lcl
patient
show
reduc
capac
respond
antigenspecif
stimul
activ
infect
fact
cell
display
low
cytotox
produc
littl
upon
stimul
therefor
show
typic
sign
function
exhaust
hernandezruiz
et
al
strikingli
effector
function
could
restor
vitro
stimul
agonist
highlight
potenti
therapeut
benefit
reviv
cell
function
dcl
patient
contrast
cutan
viscer
form
leishmaniasi
cell
seem
correl
cure
contribut
immun
respons
mucocutan
infect
ml
cell
seem
implic
pathogenesi
diseas
inde
high
number
cytotox
cell
observ
ml
patient
barralnetto
et
al
brodskyn
et
al
moreov
recruit
granzym
cell
associ
lesion
progress
faria
et
al
suggest
ctl
may
contribut
immunopatholog
develop
ml
associ
presenc
ctl
also
high
frequenc
activ
cell
extrem
tnf
product
reduc
control
inflamm
due
low
express
receptor
gaze
et
al
faria
et
al
furthermor
cell
also
found
ml
patient
boaventura
et
al
consequ
neutrophil
typic
recruit
inflammatori
respons
also
detect
necrot
perinecrot
area
boaventura
et
al
suggest
neutrophil
togeth
ctl
may
involv
tissu
injuri
develop
immunopatholog
taken
togeth
literatur
show
cell
activ
particip
fight
leishmania
infect
human
presenc
correl
cure
contrast
cell
ml
patient
contribut
diseas
exacerb
vaccin
human
heatkil
leishmania
recombin
parasit
protein
far
fail
induc
longterm
immun
recoveri
natur
experiment
infect
provid
proper
protect
sever
trial
analyz
protect
effect
autoclav
l
major
plu
bcg
versu
bcg
alon
assess
cumul
incid
cutan
leishmaniasi
caus
l
tropica
sharifi
et
al
l
major
momeni
et
al
vl
khalil
et
al
caus
l
donovani
although
trial
show
signific
effect
diseas
incid
vaccin
induc
skin
test
convers
provid
limit
protect
addit
studi
show
immun
colombian
soldier
three
dose
l
amazonensi
alon
nonprotect
velez
et
al
human
diseas
evid
mix
helper
cytokin
profil
present
heal
protect
reinfect
associ
domin
cell
find
suggest
cytokin
balanc
activ
suppress
activ
macrophag
harbor
leishmania
parasit
turn
determin
outcom
infect
thu
treatment
antigenadjuv
formul
alter
type
helper
respons
may
chang
cours
diseas
dacruz
et
al
roger
titu
mohajeri
purpos
differ
vaccin
strategi
examin
anim
model
includ
leishman
modabb
kill
parasit
grimaldi
live
attenu
parasit
titu
et
al
subsequ
subunit
vaccin
compos
recombin
nativ
protein
differ
stage
parasit
life
cycl
dna
vaccin
skeiki
et
al
webb
et
al
stager
et
al
bottrel
et
al
camposneto
et
al
rafati
et
al
coler
et
al
latter
two
strategi
encompass
candid
lack
cpb
cpa
tsa
leif
lpg
shown
promis
result
murin
model
nonetheless
recombin
fusion
protein
tsa
leif
progress
phase
ii
clinic
trial
llanoscuenta
et
al
chakravarti
et
al
nowaday
clear
cell
play
import
role
mechan
cure
resist
leishmania
infect
either
product
activ
macrophag
direct
kill
parasit
macrophag
combin
effect
cell
associ
protect
leishmania
reinfect
murin
model
howev
induct
cell
subset
human
seem
also
relat
heal
process
today
sever
report
differ
leishmani
antigen
elicit
ctl
respons
colmenar
et
al
stager
et
al
basu
et
al
cpb
rafati
et
al
nucleosom
histon
iborra
et
al
lmacin
farajnia
et
al
tsa
coler
et
al
essenti
point
consid
vaccin
design
heterogen
popul
human
hla
polymorph
effect
vaccin
complex
parasit
infect
leishmania
would
requir
multival
vaccin
compos
sever
antigen
enhanc
possibl
cover
good
number
mhc
type
possibl
either
recombin
fusion
protein
encompass
whole
antigen
vaccin
compos
peptid
differ
antigen
camposneto
et
al
rafati
et
al
mendez
et
al
latter
strategi
call
polytop
vaccin
find
way
vaccinolog
extraordinari
properti
especi
abil
direct
immun
respons
toward
induct
ctl
sbai
et
al
schirmbeck
et
al
robinson
amara
ctl
respons
play
pivot
role
defens
virus
tumor
cell
polytop
vaccin
found
way
field
still
report
leishmaniasi
even
shown
ctl
could
import
protect
longlast
resist
infect
recent
took
advantag
potenti
immunoinformat
tool
screen
l
major
epitop
could
present
hla
preval
hla
supertyp
iranian
popul
vitro
stimul
recal
memori
cell
leishmaniainfect
individu
intracellular
cytokin
assay
cell
confirm
hla
posit
individu
recov
l
major
infect
success
gener
cell
respons
peptid
deriv
sey
et
al
furthermor
walden
cowork
map
cell
epitop
kinetoplastid
membran
protein
l
major
via
classic
map
differ
human
hla
class
allel
basu
et
al
gazzinelli
cowork
studi
cell
respons
leishmania
antigen
map
cell
epitop
balbc
mice
resend
et
al
laouini
cowork
guerfali
et
al
dumonteil
cowork
dumonteil
start
genomewid
screen
novel
epitop
use
combin
cell
epitop
predict
tool
success
valid
epitop
balbc
mice
although
understudi
cell
appear
play
import
role
immun
respons
leishmania
infect
pilot
studi
murin
model
vl
also
demonstr
adopt
transfer
antigenspecif
cell
polley
et
al
reactiv
cell
respons
therapeut
vaccin
joshi
et
al
result
control
parasit
growth
better
understand
mode
activ
specif
effector
function
variou
cell
subset
gener
leishmania
infect
could
amelior
design
vaccin
novel
therapeut
intervent
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
